|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12P 21/02 | (2006.01) |
| C07K 14/50 | (2013.01) | ||
| C07K 14/50 | (2006.01) | ||
| G01N 33/92 | (2013.01) | ||
| A61K 38/18 | (2006.01) | ||
| G01N2500/04 | (2013.01) | ||
| A61P 1/12 | (2006.01) | ||
| G01N2800/04 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| G01N2800/08 | (2013.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61K 38/1825 | (2013.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 1/12 | (2018.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Number of the document | 2938740 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13868063.2 |
| Date of filing the European patent application | 2013-12-26 | |
| (97) | Date of publication of the European application | 2015-11-04 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/077782 |
| Date | 2013-12-26 |
| (87) | Number | WO 2014/105939 |
| Date | 2014-07-03 |
| (30) | Number | Date | Country code |
| 201261746499 P | 2012-12-27 | US | |
| 201361779604 P | 2013-03-13 | US | |
| 201361887129 P | 2013-10-04 | US |
| (72) |
LING, Lei , US
LUO, Jian , US
|
| (73) |
NGM Biopharmaceuticals, Inc. ,
333 Oyster Point Blvd., South San Francisco CA 94080,
US
|
| (54) | CHIMERIC FGF19 PEPTIDES FOR USE IN TREATING BILE ACID DISORDERS |
| CHIMERIC FGF19 PEPTIDES FOR USE IN TREATING BILE ACID DISORDERS |